Comparison of serological assays in human middle east respiratory syndrome (MERS)-coronavirus infection

Eurosurveillance

Volumn 20, Issue 41, 2015, Pages

  Park, S W ^a   Perera, R A P M ^b   Choe, P G ^a   Lau, E H Y ^b   Choi, S J ^a   Chun, J Y ^a   Oh, H S ^a   Song, K ^a   Bang, J H ^a   Kim, E S ^a   Kim, H B ^a   Park, W B ^a   Kim, N J ^a   Poon, L L M ^b   Peiris, Malik ^b,c   Oh, Myoung Don ^a  

^a Seoul National University College of Medicine   (South Korea)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CORONAVIRUS INFECTION; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PLAQUE REDUCTION NEUTRALISATION TEST; PSEUDOPARTICLE NEUTRALISATION TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; VIRUS NEUTRALIZATION; ADULT; ANIMAL; BLOOD; CAMEL; COMPARATIVE STUDY; CORONAVIRUS INFECTIONS; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PROCEDURES; VIROLOGY;

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAMELS; CORONAVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NEUTRALIZATION TESTS;

EID: 84965091767     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.41.30042     Document Type: Article

References (15)

1. World Health Organization (WHO). WHO statement on the tenth meeting of the IHR Emergency Committee regarding MERS. Geneva: WHO; September 3, 2015. [Accessed 12 Sep 2015]. Available from: http://www.who.int/mediacentre/news/statements/2015/ihr-emergency-committee-mers/en/
2. World Health Organization (WHO). Laboratory testing for Middle East Respiratory Syndrome Coronavirus. Interim guidance (revised). Geneva: WHO; June 2015. [Accessed 11 Sep 2015]. Available from: http://apps.who.int/iris/bitstream/10665/176982/1/WHO_MERS_LAB_15.1_eng.pdf?ua=1
3. Müller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, crosssectional, serological study. Lancet Infect Dis. 2015;15(5):559-64. DOI: 10.1016/S1473-3099(15)70090-3 PMID: 25863564
4. Meyer B, Drosten C, Müller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014;194:175-83. DOI: 10.1016/j.virusres.2014.03.018 PMID: 24670324
5. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18(36):20574. DOI: 10.2807/1560-7917.ES2013.18.36.20574 PMID: 24079378
6. Spanakis N, Tsiodras S, Haagmans BL, Raj VS, Pontikis K, Koutsoukou A, et al. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int J Antimicrob Agents. 2014;44(6):528-32. DOI: 10.1016/j.ijantimicag.2014.07.026 PMID: 25288266
7. de Sousa R, Reusken C, Koopmans M. MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol. 2014;59(1):4-11. DOI: 10.1016/j.jcv.2013.10.030 PMID: 24286807
8. Park HY, Lee EJ, Ryu YW, Kim Y, Kim H, Lee H, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill. 2015;20(25):1-6. DOI: 10.2807/1560-7917.ES2015.20.25.21169 PMID: 26132766
9. Park WB, Perera RA, Choe PG, Lau EH, Choi SJ, Chun JY, et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg Infect Dis. 2015;21(12). DOI: 10.3201/eid2112.151421
10. Chan RW, Hemida MG, Kayali G, Chu DK, Poon LL, Alnaeem A, et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014;2(10):813-22. DOI: 10.1016/S2213-2600(14)70158-4 PMID: 25174549
11. Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY, Wang P, et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014;19(23):20828. DOI: 10.2807/1560-7917.ES2014.19.23.20828 PMID: 24957744
12. Drosten C, Meyer B, Müller MA, Corman VM, Al-Masri M, Hossain R, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014;371(9):828-35. DOI: 10.1056/NEJMoa1405858 PMID: 25162889
13. Hemida MG, Al-Naeem A, Perera RA, Chin AW, Poon LL, Peiris M. Lack of middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis. 2015;21(4):699-701. DOI: 10.3201/eid2104.141949 PMID: 25811546
14. Buchy P, Vong S, Chu S, Garcia JM, Hien TT, Hien VM, et al. Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. PLoS ONE. 2010;5(5):e10864. DOI: 10.1371/journal.pone.0010864 PMID: 20532246
15. Muth D, Corman VM, Meyer B, Assiri A, Al-Masri M, Farah M, et al. Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia. J Clin Microbiol. 2015;53(9):2951-5. DOI: 10.1128/JCM.01368-15 PMID: 26157150